Business Context and Reporting Period
Company: Globus Medical, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: January 10, 2017
Context: The filing reports preliminary unaudited sales results for the three months and full year ended December 31, 2016, and provides preliminary guidance for the 2017 fiscal year. The detailed financial data is contained in a press release furnished as Exhibit 99.1.
Key Financial Metrics
The filing text itself does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These figures are referenced as being included in the attached press release (Exhibit 99.1) but are not present in the provided document text.
Material Changes
The filing announces the release of preliminary results for the period ended December 31, 2016. No specific material changes or comparative percentage growth figures are detailed within the text of this 8-K form.
Guidance, Outlook, and Risks
- Guidance: Management provided preliminary guidance for certain financial measures for the 2017 fiscal year in the accompanying press release.
- Legal Status: The information in Item 2.02 and the exhibits is deemed "furnished" rather than "filed" with the SEC under Section 18 of the Securities Exchange Act of 1934.
- Risks/Contingencies: No specific risks or contingencies are detailed in the text of this filing.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated January 10, 2017) for specific revenue and profit figures for Q4 and FY 2016.
- Verify the specific preliminary guidance targets for the 2017 fiscal year outlined in the press release.
- Confirm the unaudited nature of the reported sales results.